NasdaqGS - Nasdaq Real Time Price USD

Clover Health Investments, Corp. (CLOV)

Compare
4.3200
-0.0100
(-0.23%)
At close: 4:00:01 PM EST
4.3200
0.00
(0.00%)
After hours: 5:25:40 PM EST
Loading Chart for CLOV
DELL
  • Previous Close 4.3300
  • Open 4.3300
  • Bid 4.2900 x 2000
  • Ask 4.3400 x 2000
  • Day's Range 4.2650 - 4.5200
  • 52 Week Range 0.6060 - 4.8700
  • Volume 4,069,370
  • Avg. Volume 5,503,089
  • Market Cap (intraday) 2.165B
  • Beta (5Y Monthly) 2.00
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1900
  • Earnings Date Feb 27, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 4.80

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.

www.cloverhealth.com/en/

552

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CLOV

View More

Performance Overview: CLOV

Trailing total returns as of 2/26/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

CLOV
37.14%
S&P 500
1.27%

1-Year Return

CLOV
380.00%
S&P 500
17.49%

3-Year Return

CLOV
71.43%
S&P 500
35.84%

5-Year Return

CLOV
57.10%
S&P 500
91.12%

Compare To: CLOV

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CLOV

View More

Valuation Measures

As of 2/25/2025
  • Market Cap

    2.17B

  • Enterprise Value

    1.84B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.00

  • Price/Book (mrq)

    6.34

  • Enterprise Value/Revenue

    0.87

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -4.32%

  • Return on Assets (ttm)

    -5.66%

  • Return on Equity (ttm)

    -28.90%

  • Revenue (ttm)

    2.12B

  • Net Income Avi to Common (ttm)

    -95.94M

  • Diluted EPS (ttm)

    -0.1900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    333.05M

  • Total Debt/Equity (mrq)

    1.07%

  • Levered Free Cash Flow (ttm)

    103.22M

Research Analysis: CLOV

View More

People Also Watch